Document Auto Tags
Document Information
Title: Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
Source: https://storage.googleapis.com/polarys-documents/uploads/b87e91b9-caff-4606-aa4e-ef37814702ca.txt
Content Type: press_release
Word Count: 2757
Applied Auto Tags
| Auto Tag | Description | Extracted Value | Confidence | Applied | Actions |
|---|---|---|---|---|---|
| Executives | No description | Stephanie Fradette | N/A | N/A | |
| Communication Type | No description | Press Release | N/A | N/A | |
| CEO | No description | The most prominent company mentioned in the document is Biogen Inc. The document was published on June 18, 2025., According to multiple sources, Christopher Viehbacher (also referred to as Chris Viehbacher) was the President and Chief Executive Officer of Biogen Inc. in June 2025. He joined Biogen in November 2022. Christopher Viehbacher was discussed in articles published in February, March, and May 2025 as the CEO of Biogen. Additionally, a filing from June 2, 2025, also confirms his role as CEO., Christopher Viehbacher | N/A | N/A | |
| Company | No description | Biogen | N/A | N/A | |
| CEO | No description | Christopher Viehbacher | N/A | N/A |
About Auto Tags
Automatic Extraction
Auto tags use AI to automatically extract specific information from this document based on predefined rules.
Re-apply Tags
You can re-apply auto tags to get updated extractions if the auto tag rules have been modified.
Remove Tags
Remove individual auto tags or use "Remove All Tags" to bulk remove all applied tags at once.